US HB1035 | 2019-2020 | 116th Congress

Status

Spectrum: Slight Partisan Bill (Republican 22-13)
Status: Introduced on February 7 2019 - 25% progression
Action: 2019-02-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prescription Drug Price Transparency Act

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug Price Transparency Act

Sponsors


History

DateChamberAction
2019-02-07HouseReferred to the Subcommittee on Health.
2019-02-07HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07HouseIntroduced in House

Same As/Similar To

HB1332 (Related) 2019-02-26 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments

feedback